206 related articles for article (PubMed ID: 35699111)
1. miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review).
Arora T; Kausar MA; Aboelnaga SM; Anwar S; Hussain MA; Sadaf S; Kaur S; Eisa AA; Shingatgeri VMM; Najm MZ; Aloliqi AA
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35699111
[TBL] [Abstract][Full Text] [Related]
2. Regulatory role of microRNAs in cancer through Hippo signaling pathway.
Astamal RV; Maghoul A; Taefehshokr S; Bagheri T; Mikaeili E; Derakhshani A; Delashoub M; Taefehshokr N; Isazadeh A; Hajazimian S; Tran A; Baradaran B
Pathol Res Pract; 2020 Dec; 216(12):153241. PubMed ID: 33065484
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between Hippo signalling and miRNAs in tumour progression.
Li N; Xie C; Lu N
FEBS J; 2017 Apr; 284(7):1045-1055. PubMed ID: 27973704
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective.
Samji P; Rajendran MK; Warrier VP; Ganesh A; Devarajan K
Cell Signal; 2021 Feb; 78():109858. PubMed ID: 33253912
[TBL] [Abstract][Full Text] [Related]
5. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.
Chaulk SG; Lattanzi VJ; Hiemer SE; Fahlman RP; Varelas X
J Biol Chem; 2014 Jan; 289(4):1886-91. PubMed ID: 24324261
[TBL] [Abstract][Full Text] [Related]
6. The Hippo signaling pathway in gastric cancer.
Cao Z; An L; Han Y; Jiao S; Zhou Z
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):893-903. PubMed ID: 36924251
[TBL] [Abstract][Full Text] [Related]
7. A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis.
Azad T; Nouri K; Janse van Rensburg HJ; Maritan SM; Wu L; Hao Y; Montminy T; Yu J; Khanal P; Mulligan LM; Yang X
Oncogene; 2020 Jan; 39(2):334-355. PubMed ID: 31477837
[TBL] [Abstract][Full Text] [Related]
8. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.
Mori M; Triboulet R; Mohseni M; Schlegelmilch K; Shrestha K; Camargo FD; Gregory RI
Cell; 2014 Feb; 156(5):893-906. PubMed ID: 24581491
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide identification of microRNA targets reveals positive regulation of the Hippo pathway by miR-122 during liver development.
Zhang Y; Tan YY; Chen PP; Xu H; Xie SJ; Xu SJ; Li B; Li JH; Liu S; Yang JH; Zhou H; Qu LH
Cell Death Dis; 2021 Dec; 12(12):1161. PubMed ID: 34907157
[TBL] [Abstract][Full Text] [Related]
10. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
11. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
[TBL] [Abstract][Full Text] [Related]
12. Hippo signaling promotes JNK-dependent cell migration.
Ma X; Wang H; Ji J; Xu W; Sun Y; Li W; Zhang X; Chen J; Xue L
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1934-1939. PubMed ID: 28174264
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the role of the Hippo pathway in cancer.
Han Y
J Transl Med; 2019 Apr; 17(1):116. PubMed ID: 30961610
[TBL] [Abstract][Full Text] [Related]
15. Hippo-YAP signaling pathway: A new paradigm for cancer therapy.
Ma Y; Yang Y; Wang F; Wei Q; Qin H
Int J Cancer; 2015 Nov; 137(10):2275-86. PubMed ID: 25042563
[TBL] [Abstract][Full Text] [Related]
16. Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y
Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor.
Sebio A; Lenz HJ
Clin Cancer Res; 2015 Nov; 21(22):5002-7. PubMed ID: 26384319
[TBL] [Abstract][Full Text] [Related]
18. Hippo Signaling in Embryogenesis and Development.
Wu Z; Guan KL
Trends Biochem Sci; 2021 Jan; 46(1):51-63. PubMed ID: 32928629
[TBL] [Abstract][Full Text] [Related]
19. The two sides of Hippo pathway in cancer.
Li FL; Guan KL
Semin Cancer Biol; 2022 Oct; 85():33-42. PubMed ID: 34265423
[TBL] [Abstract][Full Text] [Related]
20. Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs.
Sharma U; Tuli HS; Uttam V; Choudhary R; Sharma B; Sharma U; Prakash H; Jain A
Pharmacol Res; 2022 Dec; 186():106523. PubMed ID: 36377125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
